IGM Biosciences Inc logo

IGM Biosciences Inc

NAS:IGMS (USA)  
$ 16.41 +1.03 (+6.7%) 11:08 PM EST
P/E:
At Loss
P/B:
2.14
Market Cap:
$ 702.78M
Enterprise V:
$ 217.61M
Volume:
189.74K
Avg Vol (2M):
158.58K
Also Trade In:
Volume:
189.74K
Market Cap $:
702.78M
PE Ratio:
At Loss
Avg Vol (2M):
158.58K
Enterprise Value $:
217.61M
PB Ratio:
2.14

Business Description

Description
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.
Name Current Vs Industry Vs History
Cash-To-Debt 16.71
Equity-to-Asset 0.61
Debt-to-Equity 0.09
Debt-to-EBITDA -0.13
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.14
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -16.4
3-Year EPS without NRI Growth Rate -17.1
3-Year FCF Growth Rate -13.4
Name Current Vs Industry Vs History
5-Day RSI 40.3
9-Day RSI 34.16
14-Day RSI 34.93
6-1 Month Momentum % 4.32
12-1 Month Momentum % 38.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.79
Quick Ratio 10.79
Cash Ratio 10.55

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -63.8

Financials (Next Earnings Date:2023-03-29 Est.)

IGMS's 30-Y Financials

How IGM Biosciences Inc (IGMS) Makes Its Money

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:IGMS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

IGM Biosciences Inc Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.697
EPS (TTM) ($) -5.68
Beta 0.06
Volatility % 90.87
14-Day RSI 34.93
14-Day ATR ($) 1.213676
20-Day SMA ($) 18.7255
12-1 Month Momentum % 38.2
52-Week Range ($) 12.67 - 35.98
Shares Outstanding (Mil) 42.83

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

IGM Biosciences Inc Filings

Document Form Filing Date
No Filing Data

IGM Biosciences Inc Stock Events

Event Date Price($)
No Event Data

IGM Biosciences Inc Frequently Asked Questions

What is IGM Biosciences Inc(IGMS)'s stock price today?
The current price of IGMS is $16.41. The 52 week high of IGMS is $35.98 and 52 week low is $12.67.
When is next earnings date of IGM Biosciences Inc(IGMS)?
The next earnings date of IGM Biosciences Inc(IGMS) is 2023-03-29 Est..
Does IGM Biosciences Inc(IGMS) pay dividends? If so, how much?
IGM Biosciences Inc(IGMS) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1